MedTrace Logo

Treatment of Androgenetic Alopecia in Females, 12 Beam

NCT01016964 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2012-09-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 12 beam model for androgenetic alopecia in females when treatment is applied as directed.

Conditions

Interventions

DEVICE

HairMax LaserComb 2009 model 12 beam

HairMax LaserComb

DEVICE

Sham Device

Sham Device

Sponsors & Collaborators

  • Lexington International, LLC

    lead INDUSTRY

Principal Investigators

  • Maria Hordinsky, M.D. · University of Minnesota

  • Wilma Bergfeld, M.D. · The Cleveland Clinic

  • Lawrence Schachner, M.D. · University of Miami

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01016964 on ClinicalTrials.gov